<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://dermfield.com/articles/transdermal-platform-bypasses-500-dalton-rule-aims-at-tumor-acidity</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Transdermal Platform Bypasses 500-Dalton Rule, Aims at Tumor Acidity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/no-good-evidence-oral-collagen-reverses-skin-ageing-dermatologist-says</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>No Good Evidence Oral Collagen Reverses Skin Ageing, Dermatologist Says</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/estrogen-therapy-linked-to-doubled-odds-of-porphyria-cutanea-tarda</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Estrogen therapy linked to doubled odds of porphyria cutanea tarda</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/multidisciplinary-vitiligo-care-extends-past-dermatology</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Multidisciplinary Vitiligo Care Extends Past Dermatology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/hormones-drive-psoriasis-and-eczema-flares-differently-in-women</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Hormones Drive Psoriasis and Eczema Flares Differently in Women</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/daily-sunscreen-cut-skin-ageing-24-what-koreas-prevention-model-offers-uk-skin-p</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Daily Sunscreen Cut Skin Ageing 24% — What Korea’s Prevention Model Offers UK Skin Pros</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/bitopertin-delivers-3-5-years-of-sun-tolerance-in-epp-trial-patient</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Bitopertin Delivers 3.5 Years of Sun Tolerance in EPP Trial Patient</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dermatologist-rates-anti-aging-toolkit-sculptra-first-salmon-sperm-last</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Dermatologist Rates Anti-Aging Toolkit: Sculptra First, Salmon Sperm Last</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/cytrellis-adds-micro-coring-training-to-miami-nurse-practitioners</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Cytrellis Adds Micro-Coring Training to Miami Nurse Practitioners</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/galderma-adds-two-director-candidates-as-its-cfo-departs</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Galderma Adds Two Director Candidates as Its CFO Departs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/jak-inhibitors-in-alopecia-areata-safety-goals-and-why-stopping-treatment-backfi</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>JAK Inhibitors in Alopecia Areata: Safety, Goals and Why Stopping Treatment Backfires</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/over-half-of-women-learn-menopause-skin-changes-only-by-living-them</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Over Half of Women Learn Menopause Skin Changes Only by Living Them</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/mrna-vaccine-cuts-skin-cancer-recurrence-and-death-by-42-in-two-years</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>mRNA vaccine cuts skin cancer recurrence and death by 42% in two years</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/daily-sunscreen-use-linked-to-24-less-skin-aging-progression</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Daily Sunscreen Use Linked to 24% Less Skin-Aging Progression</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/starboard-triplet-hits-33-month-pfs-in-braf-mutant-melanoma</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>STARBOARD Triplet Hits 33-Month PFS in BRAF-Mutant Melanoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dermatology-headlines-pasi-data-and-label-changes</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>October 2026 Dermatology Headlines: PASI Data and Label Changes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/epp-afamelanotide-trial-gave-mr-willis-hours-of-sun-tolerance</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>EPP afamelanotide trial gave Mr. Willis hours of sun tolerance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/probiotics-show-uneven-benefit-in-three-skin-diseases</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Probiotics Show Uneven Benefit in Three Skin Diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/selecting-biologics-for-moderate-to-severe-hidradenitis-suppurativa</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Selecting Biologics for Moderate-to-Severe Hidradenitis Suppurativa</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/prifemilast-reaches-pasi-75-in-57-4-at-week-16-in-phase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Prifemilast Reaches PASI 75 in 57.4% at Week 16 in Phase 3</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/winter-skin-care-little-rock-dermatologist-maps-seasonal-barrier-repair</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Winter Skin Care: Little Rock Dermatologist Maps Seasonal Barrier Repair</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/nomelcitinib-tops-phase-3-endpoints-in-plaque-psoriasis</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Nomelcitinib tops Phase 3 endpoints in plaque psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/postoperative-melanoma-vaccine-lowers-recurrence-or-death-risk-42</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Postoperative melanoma vaccine lowers recurrence-or-death risk 42%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/skin-cancer-signs-patients-miss-sores-that-won-t-heal-and-hidden-spots</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Skin Cancer Signs Patients Miss: Sores That Won&apos;t Heal and Hidden Spots</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/xerf-arrives-in-the-uk-promising-early-data-4-500-price-tag</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>XERF arrives in the UK: promising early data, £4,500 price tag</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/remibrutinib-doubles-complete-response-rates-in-phase-3-cindu-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Remibrutinib Doubles Complete-Response Rates in Phase 3 CIndU Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/volufiline-s-filler-in-a-bottle-claims-rest-on-a-28-woman-trial-that-missed-sign</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Volufiline&apos;s &apos;Filler in a Bottle&apos; Claims Rest on a 28-Woman Trial That Missed Significance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/pantethine-shows-proof-of-concept-efficacy-as-adjunct-psoriasis-therapy</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Pantethine Shows Proof-of-Concept Efficacy as Adjunct Psoriasis Therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/ebglyss-clears-hand-and-foot-eczema-in-53-of-patients-at-16-weeks</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Ebglyss Clears Hand and Foot Eczema in 53% of Patients at 16 Weeks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/patient-input-should-begin-before-psoriasis-research-is-designed</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Patient input should begin before psoriasis research is designed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/melanoma-aftercare-programme-selected-for-digifest-showcase</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Melanoma Aftercare Programme Selected for DigiFest Showcase</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/prolonged-kangri-use-linked-to-aggressive-skin-cancer-in-kashmir</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Prolonged Kangri Use Linked to Aggressive Skin Cancer in Kashmir</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/lab-study-navtemadlin-strengthens-melanoma-targeting-t-cells</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T15:29:01.229Z</news:publication_date>
      <news:title>Lab study: Navtemadlin strengthens melanoma-targeting T cells</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/navtemadlin-boosts-engineered-t-cell-killing-of-melanoma-in-vitro</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T14:19:00.767Z</news:publication_date>
      <news:title>Navtemadlin boosts engineered T-cell killing of melanoma in vitro</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/loccitane-sells-elemis-after-seven-years-in-undisclosed-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T14:04:00.755Z</news:publication_date>
      <news:title>L’Occitane Sells Elemis After Seven Years in Undisclosed Deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/uk-cosmetic-regulation-is-a-confusing-mess-mps-warn</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T13:14:00.725Z</news:publication_date>
      <news:title>UK Cosmetic Regulation Is a &apos;Confusing Mess&apos;, MPs Warn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/unilever-invests-35-million-in-ai-led-indian-r-d-hubs</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T13:09:00.714Z</news:publication_date>
      <news:title>Unilever invests €35 million in AI-led Indian R&amp;D hubs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/pdrn-for-skin-and-hair-early-signals-real-world-limits</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T12:44:00.701Z</news:publication_date>
      <news:title>PDRN for Skin and Hair: Early Signals, Real-World Limits</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/kearney-forecasts-a-937-billion-beauty-wellness-market</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T12:44:00.701Z</news:publication_date>
      <news:title>Kearney Forecasts a $937 Billion Beauty-Wellness Market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/black-nail-stripe-wider-than-3-mm-when-pigmented-bands-signal-melanoma</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T11:59:02.967Z</news:publication_date>
      <news:title>Black Nail Stripe Wider Than 3 mm? When Pigmented Bands Signal Melanoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/rls-1496-cut-actinic-keratosis-lesion-counts-by-49-in-four-weeks</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T10:14:00.582Z</news:publication_date>
      <news:title>RLS-1496 cut actinic keratosis lesion counts by 49% in four weeks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/routine-pest-screening-found-61-5-positive-for-psoriatic-arthritis</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T10:14:00.582Z</news:publication_date>
      <news:title>Routine PEST screening found 61.5% positive for psoriatic arthritis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/fewer-than-half-of-multisite-mmp-patients-reach-remission-at-all-sites</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T08:39:00.527Z</news:publication_date>
      <news:title>Fewer Than Half of Multisite MMP Patients Reach Remission at All Sites</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/ige-above-60-iu-ml-predicts-deeper-ustekinumab-clearance-in-psoriasis</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T07:09:00.446Z</news:publication_date>
      <news:title>IgE Above 60 IU/mL Predicts Deeper Ustekinumab Clearance in Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/body-care-sales-hit-523m-in-europe-as-face-grade-actives-move-south</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T06:13:47.807Z</news:publication_date>
      <news:title>Body Care Sales Hit €523m in Europe as Face-Grade Actives Move South</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/c-75-000-westbury-award-opens-for-calgary-led-melanoma-research</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-05T03:03:49.218Z</news:publication_date>
      <news:title>C$75,000 Westbury Award Opens for Calgary-Led Melanoma Research</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/military-match-for-dermatology-branch-by-branch-spot-counts</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T23:03:47.247Z</news:publication_date>
      <news:title>Military Match for Dermatology: Branch-by-Branch Spot Counts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/ucsf-s-wilson-liao-named-dermatology-chair-at-northwestern</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T19:58:40.388Z</news:publication_date>
      <news:title>UCSF&apos;s Wilson Liao Named Dermatology Chair at Northwestern</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dsm-firmenich-q3-sales-pass-2-3bn-on-beauty-volume-growth</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T13:23:40.087Z</news:publication_date>
      <news:title>DSM-Firmenich Q3 Sales Pass €2.3bn on Beauty Volume Growth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/california-dermatologist-gets-15-years-for-45m-medicare-botox-fraud</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T11:53:40.027Z</news:publication_date>
      <news:title>California Dermatologist Gets 15 Years for $45M Medicare Botox Fraud</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/estrogen-use-raises-rare-sun-triggered-skin-disorder-risk-2-5-fold</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T11:18:39.987Z</news:publication_date>
      <news:title>Estrogen Use Raises Rare Sun-Triggered Skin Disorder Risk 2.5-Fold</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://dermfield.com/articles/dragon-fruit-stem-cell-active-takes-gold-at-in-cosmetics-asia</loc>
    <news:news>
      <news:publication>
        <news:name>Derm Field</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04T09:18:39.852Z</news:publication_date>
      <news:title>Dragon Fruit Stem Cell Active Takes Gold at in-cosmetics Asia 2026</news:title>
    </news:news>
  </url>
</urlset>
